Page last updated: 2024-10-29

indirubin-3'-monoxime and Fatty Liver

indirubin-3'-monoxime has been researched along with Fatty Liver in 1 studies

indirubin-3'-monoxime: has antiangiogenic activity
indirubin-3'-monoxime : A member of the class of biindoles that is indirubin in which the keto group at position 3' has undergone condensation with hydroxylamine to form the corresponding oxime.

Fatty Liver: Lipid infiltration of the hepatic parenchymal cells resulting in a yellow-colored liver. The abnormal lipid accumulation is usually in the form of TRIGLYCERIDES, either as a single large droplet or multiple small droplets. Fatty liver is caused by an imbalance in the metabolism of FATTY ACIDS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Teodoro, JS1
Varela, AT1
Duarte, FV1
Gomes, AP1
Palmeira, CM1
Rolo, AP1

Other Studies

1 other study available for indirubin-3'-monoxime and Fatty Liver

ArticleYear
Indirubin and NAD
    European journal of clinical investigation, 2018, Volume: 48, Issue:6

    Topics: Adenosine Triphosphate; Animals; Antibiotics, Antineoplastic; Calcium; Cyclophilins; Cytochromes c;

2018